Insider · CIK 0001822629

Lalwani Nikhil

Reports to the SEC for 1 company · PRINCETON, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001822629

Forms 4 and 5

Insider transactions

49 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-10-15	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−5,400 sh	$71.89	−$388K	333,689
2026-09-15	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−5,400 sh	$71.00	−$383K	339,089
2026-08-25	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−5,400 sh	$74.30	−$401K	344,489
2026-05-11	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−55K sh	$77.57	−$4.27M	349,889
2026-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−17.1K sh	$74.04	−$1.26M	404,889
2026-02-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−12.2K sh	$73.90	−$903K	421,949
2026-02-26	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+75.6K sh	$77.15	+$5.83M	434,166
2026-02-14	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−10.3K sh	$77.36	−$797K	358,574
2026-02-12	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−11.7K sh	$76.70	−$896K	368,872
2026-02-11	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−30.7K sh	$76.25	−$2.34M	380,560
2025-08-12	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−57K sh	$85.93	−$4.89M	411,219
2025-03-23	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−17.5K sh	$64.26	−$1.12M	468,179
2025-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−17.1K sh	$60.62	−$1.03M	485,634
2025-02-28	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−12.2K sh	$61.89	−$756K	502,694
2025-02-14	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−7,799 sh	$58.92	−$460K	514,910
2025-02-12	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+91.4K sh	—	—	461,777
2025-02-12	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+60.9K sh	—	—	522,709
2024-11-26	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	Director, PRESIDENT & CEO	MExercise/Conversion	+30K sh	$29.00	+$870K	403,859
2024-11-26	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−30K sh	$57.95	−$1.74M	373,859
2024-11-26	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−3,481 sh	$58.30	−$203K	370,378
2024-11-26	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Director, PRESIDENT & CEO	MExercise/Conversion	−30K sh	$29.00	−$870K	138,027
2024-09-08	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−3,646 sh	$60.51	−$221K	373,859
2024-05-14	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−16.7K sh	$66.10	−$1.1M	377,505
2024-03-23	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−17.5K sh	$69.58	−$1.21M	394,174
2024-03-08	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−16.3K sh	$67.13	−$1.09M	411,629
2024-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−17.1K sh	$66.71	−$1.14M	427,921
2024-03-06	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−29K sh	$65.52	−$1.9M	444,981
2024-02-29	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−10K sh	$67.67	−$678K	473,946
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+80.5K sh	—	—	430,274
2024-02-14	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+53.7K sh	—	—	483,960
2023-09-08	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−3,646 sh	$61.94	−$226K	349,744
2023-08-15	ANIPANI PHARMACEUTICALS INCM Exercise/Conversion	Director, PRESIDENT & CEO	MExercise/Conversion	+11.6K sh	$29.00	+$337K	365,006
2023-08-15	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−11.6K sh	$61.13	−$710K	353,390
2023-08-15	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)M Exercise/Conversion	Director, PRESIDENT & CEO	MExercise/Conversion	−11.6K sh	$29.00	−$337K	168,027
2023-08-11	ANIPANI PHARMACEUTICALS INCS Sale	Director, PRESIDENT & CEO	SSale	−56.7K sh	$57.75	−$3.27M	353,390
2023-03-23	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−17.5K sh	$37.82	−$660K	250,840
2023-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−9,397 sh	$44.23	−$416K	272,560
2023-03-07	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−4,265 sh	$44.23	−$189K	268,295
2023-02-28	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+95.5K sh	—	—	346,370
2023-02-28	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+63.7K sh	—	—	410,056
2022-09-08	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−3,646 sh	$37.61	−$137K	281,957
2022-04-27	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+33.4K sh	—	—	285,603
2022-03-24	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+100K sh	—	—	252,251
2022-03-23	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−17.5K sh	$27.03	−$472K	152,196
2022-03-21	ANIPANI PHARMACEUTICALS INCP Purchase	Director, PRESIDENT & CEO	PPurchase	+7,224 sh	$27.69	+$200K	169,650
2021-09-08	ANIPANI PHARMACEUTICALS INCF Tax Payment	Director, PRESIDENT & CEO	FTax Payment	−2,577 sh	$28.20	−$72.7K	162,426
2021-03-23	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+136K sh	—	—	165,003
2020-09-08	ANIPANI PHARMACEUTICALS INCA Award	Director, PRESIDENT & CEO	AAward	+28.5K sh	—	—	28,508
2020-09-08	ANIPANI PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Director, PRESIDENT & CEO	AAward	+180K sh	—	—	179,643

Recent filings

Accepted (ET)
Oct 164
Lalwani Nikhil0001822629-26-000018
SEC(opens sec.gov)
Sep 164
Lalwani Nikhil0001822629-26-000016
SEC(opens sec.gov)
Aug 264
Lalwani Nikhil0001822629-26-000014
SEC(opens sec.gov)
May 134
Lalwani Nikhil0001822629-26-000011
SEC(opens sec.gov)
Mar 104
Lalwani Nikhil0001822629-26-000008
SEC(opens sec.gov)
Mar 24
Lalwani Nikhil0001822629-26-000006
SEC(opens sec.gov)
Feb 174
Lalwani Nikhil0001822629-26-000004
SEC(opens sec.gov)
Feb 134
Lalwani Nikhil0001822629-26-000002
SEC(opens sec.gov)
Aug 144
Lalwani Nikhil0001822629-25-000010
SEC(opens sec.gov)
Mar 254
Lalwani Nikhil0001822629-25-000008
SEC(opens sec.gov)
Mar 144
Lalwani Nikhil0001822629-25-000006
SEC(opens sec.gov)
Mar 44
Lalwani Nikhil0001822629-25-000004
SEC(opens sec.gov)
Feb 184
Lalwani Nikhil0001822629-25-000002
SEC(opens sec.gov)
Nov 274
Lalwani Nikhil0001822629-24-000014
SEC(opens sec.gov)

Companies

ANI PHARMACEUTICALS INCDirector, PRESIDENT & CEOANIP

Address

C/O ANI PHARMACEUTICALS, INC. 104 CARNEGIE CENTER, SUITE 300

PRINCETON, NJ, 08540